2015
DOI: 10.1016/j.molcatb.2015.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced enzymatic activity of phenylalanine dehydrogenase caused by cyclodextrins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…is employed to convert Phe into phenylpyruvate and stoichiometrically reduce NAD + into NADH (Scheme 1a). The pH value favorable for the Phe conversion and NADH formation is 10.5, 32–35 which is higher than that suitable for NTR catalyzing RF in the fluorescence readout process (pH 7.4). 31,36 A simple solution adopting different buffers for these cascade reactions is proposed to resolve this situation.…”
Section: Resultsmentioning
confidence: 87%
“…is employed to convert Phe into phenylpyruvate and stoichiometrically reduce NAD + into NADH (Scheme 1a). The pH value favorable for the Phe conversion and NADH formation is 10.5, 32–35 which is higher than that suitable for NTR catalyzing RF in the fluorescence readout process (pH 7.4). 31,36 A simple solution adopting different buffers for these cascade reactions is proposed to resolve this situation.…”
Section: Resultsmentioning
confidence: 87%
“…The most recent studies make extensive use of the powerful catalytical properties of enzymes in supramolecular structures to produce biosensors. In this context, different strategies for the immobilization of enzymes related to the l -phenylalanine metabolism have been proposed, with the phenylalanine dehydrogenase enzyme (PheDH) as the primary candidate. This enzyme belongs to the oxidoreductase class of enzymes and is responsible for the reversible reaction of oxidative deamination of l -phenylalanine to phenylpyruvate in the presence of NAD + as a cofactor …”
Section: Introductionmentioning
confidence: 99%
“…Many studies aimed at developing new PKU monitoring strategies, relying on several different approaches, have been published. These include enzyme-based (Gubica et al 2015;Mangombo et al 2013;Naghib, Rabiee, Omidinia, and Khoshkenar 2012;Naghib, Rabiee, Omidinia, Khoshkenara, et al 2012;Omidinia 2014a, 2014b;Omidinia, Khanehzar, et al 2013;Omidinia, Shadjou, and Hasanzadeh 2014b;Villalonga et al 2007Villalonga et al , 2008Weiss et al 2007;Zhuo Wang et al 2005), aptamer-based (Idili et al 2021), (Omidinia, Shadjou, and Hasanzadeh 2014a) and nanomaterials (Hasanzadeh et al 2009(Hasanzadeh et al , 2012Hasanzadeh, Shadjou, and Omidinia 2013;Omidinia, Shadjou, and Hasanzadeh 2013;Wu et al 2017) based electrochemical sensors, as well as immune sensors, (Kubota, Mizukoshi, and Miyano 2013) quartz crystal microbalance (QCM), (Cho et al 2017;Emir Diltemiz et al 2017;Mirmohseni, Shojaei, and Farbodi 2008) extended field gate field effect transistor (Iskierko et al 2017) and photometricbased strategies. Some of the principle challenges facing the development of an effective biosensor for PKU monitoring include (1) having a linear range which covers the 120 mol/L and 360 mol/L key threshold values for L-Phe described previously, (2) being able to detect L-Phe in patient-derived samples with low chemical interference (e.g.…”
Section: Introductionmentioning
confidence: 99%